newsfilter
← Latest News
GlobeNewswire·

LIXTE Biotechnology Holdings Regains Compliance with Nasdaq's Continued Listing Requirements

PASADENA, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. ("LIXTE" or the "Company") (NASDAQ:LIXT), a clinical stage pharmaceutical company, today announced it has received a letter from